BRCA2 p.Cys1675Trp

Variant summary

Our verdict is Uncertain significance.
+2 Uncertain · Warm
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 2 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_Moderate

The NM_000059.4(BRCA2):c.5025T>G (p.Cys1675Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene BRCA2 is a tumor suppressor gene (CancerMine: 139 TSG, 7 oncogene, 19 driver citations). The gene BRCA2 is a cancer driver gene (CancerMine: 139 TSG, 7 oncogene, 19 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.C1675= (synonymous): Likely_benign (ClinVar VariationId 186066, 3 stars); p.C1675F: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 1386782); p.C1675R: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 184360); p.C1675Y: Uncertain_significance (ClinVar VariationId 2501278, 2 stars)

Frequency

Genomes: not found (cov: 33)

Consequence

BRCA2
NM_000059.4 missense

Scores

4
12

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.435

Publications

0 publications found
Variant links:
Genes affected
BRCA2 (HGNC:1101): (BRCA2 DNA repair associated) The product of this gene in involved in maintenance of genome stability. It is involved in double-strand break repair pathways during mitotic and meiotic homologous recombination and functions in protecting DNA replication forks. The encoded protein contains sites for interactions with PALB2 and EMSY and an N-terminal DNA binding domain. It also contains a RAD51 binding domain with multiple components. It has multiple BRC repeats, an alpha helix domain, oligonucleotide binding folds, and a tower-like domain. It has a nuclear localization signal and a phosphorylation site for cyclin-dependent kinase. The C-terminus of the protein can bind single-stranded and double-stranded DNA. The product of this gene interacts with multiple proteins, including RAD51. It is involved in recruiting RAD51 filaments to DNA double-strand break sites and also in cytoplasmic division. It also acts as a tumor suppressor. Mutations in this gene or decreased expression have been implicated in multiple tumor types, including breast, ovarian, pancreatic, prostate and other cancers. [provided by RefSeq, May 2026]
BRCA2 Gene-Disease associations (from GenCC):
  • BRCA2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • Fanconi anemia complementation group D1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • pancreatic cancer, susceptibility to, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000059.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 2 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000059.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

BRCA2 NM_000059.4
MANE Select
HGVSc / HGVSpc.5025T>Gp.Cys1675Trp
Exon rankExon 11 of 27
missense
Prot: NP_000050.3UniProt: A0A7P0T9D7P51587
BRCA2 NM_001432077.1
HGVSc / HGVSpc.5025T>Gp.Cys1675Trp
Exon rankExon 11 of 27
missense
Prot: NP_001419006.1UniProt: A0A7P0T9D7P51587
BRCA2 NM_001406720.1
HGVSc / HGVSpc.5025T>Gp.Cys1675Trp
Exon rankExon 11 of 27
missense
Prot: NP_001393649.1UniProt: A0A8V8TPZ2

Ensembl Transcripts

BRCA2 ENST00000380152.8
TSL:5MANE Select
HGVSc / HGVSpc.5025T>Gp.Cys1675Trp
Exon rankExon 11 of 27
missense
Prot: ENSP00000369497.3UniProt: P51587
BRCA2 ENST00000544455.6
TSL:1
HGVSc / HGVSpc.5025T>Gp.Cys1675Trp
Exon rankExon 11 of 27
missense
Prot: ENSP00000439902.1UniProt: P51587
BRCA2 ENST00000530893.7
TSL:1
HGVSc / HGVSpc.4656T>Gp.Cys1552Trp
Exon rankExon 11 of 27
missense
Prot: ENSP00000499438.2UniProt: A0A590UJI7

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:33
GnomAD4 exome
Cov:45
GnomAD4 genome
Cov:33
Local & regional cohorts 1 source
ChinaMAP Phase 1
AF: 0.0000492
Showing 4 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Uncertain13
AlphaMissense
Benign0.16
BayesDel_addAF
Benign-0.0028T
BayesDel_noAF
Benign-0.24
CADD
Benign14
DANN
Benign0.97
Eigen
Benign-0.28
Eigen_PC
Benign-0.40
FATHMM_MKL
Benign0.13N
FuncVEP CTI
Benign0.11
GPN-Star LLR
N/A-4.1
GPN-Star score
N/A4.1
M_CAP
Uncertain0.23D
MetaRNN
Uncertain0.63D
MetaSVM
Benign-0.74T
Mutation Taster
N/A81/19polymorphism
PhyloP100
Benign0.43
PrimateAI
Benign0.24T
PROVEAN
Benign-0.59N
REVEL
Uncertain0.40
Sift
Uncertain0.010D
Sift4G
Benign0.15T
VESM-3B
Benign-7.4
Showing 23 of 23 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.